5-Lipoxygenase: a rational target for therapy of inflammatory bowel disease?
- PMID: 2180156
- DOI: 10.1016/0165-6147(90)90313-w
5-Lipoxygenase: a rational target for therapy of inflammatory bowel disease?
Similar articles
-
Inhibition of arachidonate 5-lipoxygenase by phenolic compounds.Chem Pharm Bull (Tokyo). 1986 Sep;34(9):3960-3. doi: 10.1248/cpb.34.3960. Chem Pharm Bull (Tokyo). 1986. PMID: 3815617 No abstract available.
-
5-Lipoxygenase inhibitors isolated from gardeniae fructus.Chem Pharm Bull (Tokyo). 1988 Jan;36(1):87-95. doi: 10.1248/cpb.36.87. Chem Pharm Bull (Tokyo). 1988. PMID: 3378310 No abstract available.
-
Acetohydroxamic acids as potent, selective, orally active 5-lipoxygenase inhibitors.J Med Chem. 1988 Mar;31(3):499-500. doi: 10.1021/jm00398a001. J Med Chem. 1988. PMID: 3346867 No abstract available.
-
The effects of a novel series of selective inhibitors of arachidonate 5-lipoxygenase on anaphylactic and inflammatory responses.Ann N Y Acad Sci. 1988;524:307-20. doi: 10.1111/j.1749-6632.1988.tb38554.x. Ann N Y Acad Sci. 1988. PMID: 2837965 Review.
-
The development of new antileukotriene drugs: specific leukotriene D4 antagonists and 5-lipoxygenase inhibitors.Adv Exp Med Biol. 1989;259:75-108. doi: 10.1007/978-1-4684-5700-1_4. Adv Exp Med Biol. 1989. PMID: 2560345 Review. No abstract available.
Cited by
-
New developments in the pharmacotherapy of inflammatory bowel disease.Pharm Weekbl Sci. 1992 Aug 21;14(4A):275-86. doi: 10.1007/BF01962550. Pharm Weekbl Sci. 1992. PMID: 1437510 Review.
-
Ebselen is a specific inhibitor of LTB4-mediated migration of human neutrophils.Agents Actions. 1993 Nov;40(3-4):186-90. doi: 10.1007/BF01984060. Agents Actions. 1993. PMID: 8023742
-
Nephrotic syndrome associated with N-hydroxyureas, inhibitors of 5-lipoxygenase.Arch Toxicol. 1995;69(7):480-90. doi: 10.1007/s002040050202. Arch Toxicol. 1995. PMID: 8526744
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources